The 15 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 16.30, with a high estimate of 19.38 and a low estimate of 13.70. The median estimate represents a +15.95% increase from the last price of 14.06.
The current consensus among 18 polled investment analysts is to Hold stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.16
Reporting Date Feb 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.